DEBT (Tables)

9 Months Ended

Jun. 30, 2024

Schedule of Long-Term Debt and Effective Interest Rates

Long-term debt as of June 30, 2024 and September 30, 2023 is detailed in the table below.


	June 30, 2024		September 30, 2023
Seller Note – Bolder BioPath (Related party)	$	432	$	602
Seller Note – Preclinical Research Services	484		541
Seller Payable - Orient BioResource Center	3,690		3,649
Seller Note – Histion (Related party)	120		229
Seller Note – Protypia (Related party)	—		400
Economic Injury Disaster Loan	—		140
Convertible Senior Notes	115,296		110,651
Term Loan Facility, DDTL and Incremental Term Loans	274,048		272,930
Total debt before unamortized debt issuance costs	$	394,070	$	389,142
Less: Debt issuance costs not amortized	(11,623)		(11,397)
Total debt, net of unamortized debt issuance costs	$	382,447	$	377,745
Less: Current portion	(378,550)		(7,950)
Total Long-term debt	$	3,897	$	369,795

Below are the weighted-average effective interest rates for the loans available under the Credit Agreement (as defined below):


	Three Months Ended June 30,				Nine Months Ended June 30,
	2024		2023		2024		2023
Effective interest rates:
Term Loan	11.67	%	10.25	%	11.43	%	10.29	%
Initial DDTL	11.66	%	10.22	%	11.41	%	10.31	%
Additional DDTL	11.78	%	10.35	%	11.54	%	10.47	%

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477734/942-470-50-3

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-8

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-6

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-7

+ Details